Abstract Background: Only lamivudine has been included for patients with chronic hepatitis B (CHB) in the National List of Essential Drugs (NLED), a pharmaceutical reimbursement list in Thailand. There have also been no economic evaluation studies of CHB drug treatments conducted in Thailand yet. I

SUMMARY POINTS •  End stage renal disease (ESRD) is a life-threatening condition that results in most patients requiring a lifetime of high cost renal dialysis •  Governments have grappled with the political, economic, and ethical challenges of providing treatment with their available budgets •

People with hearing loss who are registered under the Universal Health Coverage scheme areeligible to receive hearing aids from hospitals free-of-charge. However, the costs associated with this policy after having received the hearing aids must still be borne by users such as hearing aid maintenance

Hialy Gutierrez, MPH,1,2 Ashwini Shewade, MS, MSc,1 Minghan Dai, MPH,1 Pedro Mendoza-Arana, MD, MSc,3 Octavio Go´mez-Dante´s, MD, MPH,4 Nishant Jain, PhD,5 Irma Khonelidze, MPA,6 Juliet Nabyonga-Orem, MD, MSc,7 Karima Saleh, PhD,8 Yot Teerawattananon, MD, PhD,9 Sania Nishtar, SI, PhD,10 and John Hor

Why do we need to make health technology assessment (HTA) more realistic? Is HTA not realistic nowadays? The answers can be both YES and NO.HTA is a form of research for synthesising data to evaluate properties, effects, and impacts of health interventions and technology in diffe

On 29 January 2013, a side meeting entitled “the establishment and evolution of health technology assessment organisations in low- and middle-income countries”, which was co-organized by HTAsiaLink and NICE international, intended to create an open space for sharing, learning and inspiring participa

On 14August 2018, Dr. Mayfong Mayxay, Vice-Dean of the Research department at the Faculty of Postgraduate Studies in Laos University of Health Science, visited the Health Intervention and Technology Assessment Program (HITAP) to learn about Health Technology Assessment (HTA) and to discuss potential

We are very pleased to announce that the 10th HTAsiaLink Annual Conference is now open for Early Bird Registration and it will be happening in Pattaya, Thailand at Royal Cliff Grand Hotel from 30 Nov – 2 Dec, 2022! With COVID-19 still hitting hard, treatment and epidemiological p

On behalf of the Health Intervention Technology and Assessment Program (HITAP) Foundation and the National University of Singapore (NUS), we have the pleasure of inviting you to participate in the “Fruitful Research: How to Make Health Innovation Worthwhile” Workshop and witness the Signing Ceremony

COVID-19 has shown that irresepctive of national borders, the infectious disease brings multi-dimensional challenges requiring concerted global and regional efforts to address it. In contrast to the European Union and the African Union, the Association of Southeast Asian Nations (ASEAN), the regional cooperation body in Southeast Asia, has had no e